arrow
P

Patrick Schmid

hoch health ostschweiz cantonal hospital st gallen
H指数:39
被引数:6,255

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Switching to Integrase Inhibitors and Cardiovascular Disease Risk in Treatment-Experienced People With HIV: A Sequential Target Trial Emulation in the Swiss HIV Cohort Study

在瑞士艾滋病队列研究中,治疗经验丰富的HIV患者转换使用整合酶抑制剂与心血管疾病风险的序贯目标试验模拟

2026-08-070
OAAI
Similar Changes in Proviral Landscapes Over 10 Years in 40 Individuals With Diverging HIV Reservoir Dynamics and Viral Load Kinetics

40例个体中HIV储库动态和病毒载量动力学存在差异的10年间病毒基因组景观的相似变化

2026-04-010
PRE
Trends in Costs for HIV Care During a Hepatitis C Virus Early Treatment and Elimination Program: A Data Linkage Study of Claims and Swiss HIV Cohort Study Data

艾滋病病毒护理费用的趋势:一项关于索赔数据和瑞士艾滋病队列研究数据的链接研究,该研究涉及丙型肝炎病毒早期治疗和消除计划。

2025-08-010
PRE
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfection

在HIV/乙型肝炎病毒共感染患者中,替诺福韦治疗期间频繁发生乙型肝炎表面抗原(HBsAg)清除。

2025-02-250
PRE
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial
2024-10-160
OAAI
Circulating HBV RNA and Hepatitis B Core-Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy

替诺福韦治疗期间HIV/HBV合并感染和乙型肝炎表面抗原丢失的人的循环HBV RNA和乙型肝炎核心相关抗原轨迹

2024-04-160
OAAI
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV
2024-03-222
OAAI
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection

替诺福韦治疗期间乙型肝炎病毒 (HBV) 复制在人类免疫缺陷病毒/HBV合并感染中很常见

2022-10-159
OA
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (vol 12, 577, 2022)
2022-07-080
OAAI
ATRACTIB: A phase II trial of first-line (1L) atezolizumab (A) in combination with paclitaxel (P) and bevacizumab (B) in metastatic triple-negative breast cancer (mTNBC)
2022-05-010
PRE